These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9488660)

  • 1. Cyclin-dependent kinase inhibitor p16INK4A inhibits phosphorylation of RNA polymerase II by general transcription factor TFIIH.
    Serizawa H
    J Biol Chem; 1998 Mar; 273(10):5427-30. PubMed ID: 9488660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation.
    Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H
    Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of TFIIH-associated kinase activity by complex formation and its relationship with CTD phosphorylation of RNA polymerase II.
    Watanabe Y; Fujimoto H; Watanabe T; Maekawa T; Masutani C; Hanaoka F; Ohkuma Y
    Genes Cells; 2000 May; 5(5):407-23. PubMed ID: 10886368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Cdk-activating kinase subunits with transcription factor TFIIH.
    Serizawa H; Mäkelä TP; Conaway JW; Conaway RC; Weinberg RA; Young RA
    Nature; 1995 Mar; 374(6519):280-2. PubMed ID: 7885450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdk-activating kinase complex is a component of human transcription factor TFIIH.
    Shiekhattar R; Mermelstein F; Fisher RP; Drapkin R; Dynlacht B; Wessling HC; Morgan DO; Reinberg D
    Nature; 1995 Mar; 374(6519):283-7. PubMed ID: 7533895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement for TFIIH kinase activity in transcription by RNA polymerase II.
    Akoulitchev S; Mäkelä TP; Weinberg RA; Reinberg D
    Nature; 1995 Oct; 377(6549):557-60. PubMed ID: 7566158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription.
    Mäkelä TP; Parvin JD; Kim J; Huber LJ; Sharp PA; Weinberg RA
    Proc Natl Acad Sci U S A; 1995 May; 92(11):5174-8. PubMed ID: 7761469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
    Isel C; Karn J
    J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II.
    Cujec TP; Okamoto H; Fujinaga K; Meyer J; Chamberlin H; Morgan DO; Peterlin BM
    Genes Dev; 1997 Oct; 11(20):2645-57. PubMed ID: 9334327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TFIIH is negatively regulated by cdk8-containing mediator complexes.
    Akoulitchev S; Chuikov S; Reinberg D
    Nature; 2000 Sep; 407(6800):102-6. PubMed ID: 10993082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating phosphorylation of the Kin28p subunit of yeast TFIIH by Cak1p.
    Kimmelman J; Kaldis P; Hengartner CJ; Laff GM; Koh SS; Young RA; Solomon MJ
    Mol Cell Biol; 1999 Jul; 19(7):4774-87. PubMed ID: 10373527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of TFIIH transcriptional activity and TFIIH-associated cdk7 kinase activity at mitosis.
    Long JJ; Leresche A; Kriwacki RW; Gottesfeld JM
    Mol Cell Biol; 1998 Mar; 18(3):1467-76. PubMed ID: 9488463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Tat-associated RNA polymerase C-terminal domain kinase, CDK2, phosphorylates CDK7 and stimulates Tat-mediated transcription.
    Nekhai S; Zhou M; Fernandez A; Lane WS; Lamb NJ; Brady J; Kumar A
    Biochem J; 2002 Jun; 364(Pt 3):649-57. PubMed ID: 12049628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.
    Zhou M; Halanski MA; Radonovich MF; Kashanchi F; Peng J; Price DH; Brady JN
    Mol Cell Biol; 2000 Jul; 20(14):5077-86. PubMed ID: 10866664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inability to enter S phase and defective RNA polymerase II CTD phosphorylation in mice lacking Mat1.
    Rossi DJ; Londesborough A; Korsisaari N; Pihlak A; Lehtonen E; Henkemeyer M; Mäkelä TP
    EMBO J; 2001 Jun; 20(11):2844-56. PubMed ID: 11387217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutual targeting of mediator and the TFIIH kinase Kin28.
    Guidi BW; Bjornsdottir G; Hopkins DC; Lacomis L; Erdjument-Bromage H; Tempst P; Myers LC
    J Biol Chem; 2004 Jul; 279(28):29114-20. PubMed ID: 15126497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor.
    Roy R; Adamczewski JP; Seroz T; Vermeulen W; Tassan JP; Schaeffer L; Nigg EA; Hoeijmakers JH; Egly JM
    Cell; 1994 Dec; 79(6):1093-101. PubMed ID: 8001135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK.
    Feaver WJ; Svejstrup JQ; Henry NL; Kornberg RD
    Cell; 1994 Dec; 79(6):1103-9. PubMed ID: 8001136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II.
    Glover-Cutter K; Larochelle S; Erickson B; Zhang C; Shokat K; Fisher RP; Bentley DL
    Mol Cell Biol; 2009 Oct; 29(20):5455-64. PubMed ID: 19667075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of CDK7 substrate specificity by MAT1 and TFIIH.
    Yankulov KY; Bentley DL
    EMBO J; 1997 Apr; 16(7):1638-46. PubMed ID: 9130709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.